Leuko (private company)
See something wrong or missing? Let us know
Offices:Madrid, Boston
Business model:B2B
Leuko is developing PointCheck, a proprietary device to measure white blood cell levels non-invasively, which can enable improved clinical outcomes and reduced costs for immunosuppressed patients.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 1.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Leuko
Name | Criteria | |
---|---|---|
![]() |
Galgus
65%
|
|
![]() |
Jutro Medical
65%
|
|
![]() |
MOV.AI
65%
|
|
![]() |
Recycleye
65%
|
|
![]() |
ToolSense
65%
|
|
![]() |
Universal Quantum
65%
|
|
![]() |
Valka
65%
|
|
![]() |
QphoX
65%
|
|
![]() |
Synox France
65%
|
|
![]() |
Molecule.one
65%
|
|